Oncology Biomarker-Driven Trials in China
Oncology Biomarker-Driven Trials in China The Rise of Biomarker-Driven Oncology Clinical Trials in China Introduction Biomarker-driven oncology trials are transforming cancer treatment by matching therapies to genetic, molecular, and clinical signatures of patients. In China, where cancer incidence is rising sharply, the push toward precision medicine has made biomarker-driven trials a national priority. The National…